ASAlla A. Strutsenko

Alla A. Strutsenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alla A. Strutsenko has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Residual dizziness after successful repositioning maneuver in benign paroxysmal positional vertigo: the status of the issue

    by M. V. Tardov, A. V. Blagoveshchenskaya, E. A. Baklushina, А. А. Strutsenko

    Following a successful otolith repositioning maneuver for benign paroxysmal positional vertigo (BPPV), patients often experience residual dizziness, that means completely different disbalance sense characteristics. This phenomenon is usually referred to as residual dizziness (RD). This review article examines predisposing factors for RD, such as vitamin and mineral metabolism disorders and the patient’s psychological characteristics. It presents current pathogenetic concepts of RD based on otolith dysfunction, delayed central adaptation, the preservation of microstructural residual fragments, and psychogenic disturbances. It also discusses currently accepted diagnostic criteria (confirmed successful treatment of BPPV with repositioning maneuvers, complete absence of positional vertigo and objective nystagmus, and a change in the nature of the disbalance sense itself). The recommended approaches to preventing this condition, including vestibular rehabilitation, drug therapy, and correction of metabolic disorders, are described. The need for continued research aimed at finding the most effective therapy for RD is emphasized.

  • A case of non-alcoholic Wernicke’s encephalopathy in a young patient after bariatric surgery

    by O. S. Arisheva, Yu. A. Pigareva, O. P. Artyukov, I. V. Damulin, A. A. Strutsenko, L. A. Goreva, M. A. Markova, S. A. Lovchikova, R. G. Akzhigitov

    Wernicke’s encephalopathy is an acute neurological condition, the primary etiological factor of which is thiamine deficiency, most commonly associated with chronic alcohol intoxication. However, the occurrence of this condition due to other causes is frequently overlooked by clinicians, resulting in delayed diagnosis, severe cerebral and psychiatric complications, and death. The mechanisms leading to this complication are multifactorial and include inadequate nutritional intake (intractable vomiting, insufficient nutrition), increased metabolic demand (thyrotoxicosis, malignancy), and impaired absorption (surgical interventions on the gastrointestinal tract, including bariatric procedures). Within the spectrum of bariatric interventions, Wernicke’s encephalopathy is more frequently observed after malabsorptive procedures, which is attributable to the passage of food bypassing the primary sites of nutrient absorption. The difficulty in verifying the diagnosis lies in the similarity between the clinical manifestations of vitamin B1 deficiency and postoperative symptoms following bariatric surgery, limited awareness of this complication among specialists, and the lack of technical diagnostic capabilities. This article presents a clinical case of a young female patient with Wernicke encephalopathy that developed after gastric bypass surgery.

  • Neurolymphomatosis in a patient with diffuse large B-cell lymphoma: a case report and a literature review

    by N. I. Garabova, M. G. Burzhunova, P. K. Abdulmuslimova, V. I. Glinkina, N. Yu. Mansur, A. A. Strutsenko

    Neurological complications of lymphoproliferative disorders (LPDs) and lymphomas are diverse and often pose significant diagnostic challenges. In addition to direct involvement of the central and peripheral nervous systems caused by clonal proliferation of lymphoid cells with the development of brain lymphoma, as well as meningeal involvement resulting in leptomeningitis and myelitis, a variety of paraneoplastic syndromes may occur, including paraneoplastic myelitis and paraneoplastic polyneuropathy. Furthermore, iatrogenic neurological complications frequently arise during the treatment of hematologic malignancies, particularly immune effector cell-associated neurotoxicity syndrome (ICANS) related to cellular immunotherapy. Neurolymphomatosis (NL) represents a distinct entity in neurological practice. It is characterized by direct infiltration of peripheral nerves, nerve roots, plexuses, and cranial nerves by malignant lymphoid cells. This condition demonstrates marked clinical heterogeneity and, according to published data, diagnosis is often delayed by 3 to 8 months.

  • Recurrent painful ophthalmoplegic neuropathy: a case report and literature review

    by M. G. Burzhunova, N. I. Garabova, S. D. Nazarova, A. A. Strutsenko

    Recurrent painful ophthalmoplegic neuropathy (RPON) is a rare neurological syndrome characterized by recurrent attacks of unilateral headache, accompanied by paresis of one or more ocular motor nerves (most commonly the third cranial nerve, less often the fourth or sixth). This article presents a clinical case of RPON in a young female patient without MRI abnormalities but with elevated inflammatory markers. Pathogenetic mechanisms are discussed based on current literature data. A positive therapeutic effect of methylprednisolone was observed, manifested by regression of oculomotor deficits. Thus, the absence of MRI changes does not necessarily exclude the inflammatory nature of RPON, while a favorable response to corticosteroid therapy supports the role of immune-inflammatory mechanisms in its pathogenesis.

  • The effectiveness of extracorporeal techniques detoxification in pancreatic encephalopathy in a patient with pancreatic necrosis (Clinical case)

    by D. T. Nazarov, M. Yu. Persov, A. E. Klimov, E. Yu. Sadovnikova, I. V. Damulin, A. A. Strutsenko

    Pancreatic encephalopathy, characterized by a variety of focal neurological symptoms, develops in 9–35 % of patients with pancreatic diseases. Almost every patient with acute pancreatitis has a risk of developing pancreatic encephalopathy, which significantly deteriorates the course and increases mortality to 54 %. The article provides an example of the effect of extracorporeal detoxification techniques (ECDT) on the course of pancreatic necrosis, a phenomenon with neurological symptoms. The usage of ECDT is an effective method for treating pancreatic necrosis; it allows for the relief of neurological disorders caused by the development of pancreatic encephalopathy, and prevents the development, as well as helps to relieve the phenomenon of dementia of pancreatic genesis.

  • Alterations in gut microbiota composition in young adults with relapsing- remitting multiple sclerosis

    by M. V. Tardov, N. V. Sturov, A. A. Strucenko, E. V. Popova, Rf City Clinical Hospital 24, A. V. Boldin, V. A. Zhukov, Sh. Talapbek

    The gut microbiota functions as an independent organ, influencing bodily systems and disease development, though its role in multiple sclerosis (MS) pathogenesis remains unclear. This study evaluated gut microbiota composition in young individuals with relapsing-remitting MS (РРС) onset compared to healthyusing Statsoft Statistica 12, involved normality tests (Kolmogorov-Smirnov, Shapiro-Wilk), Mann-Whitney U tests (p≤0.05). Results showed РРС patients had a significant predominance of Clostridium difficile and Propionibacterium spp., while Kingella spp. and Pseudomonas aeruginosa were absent, distinguishing them from controls. РРС patients also exhibited higher fungal flora levels. Regarding the viral component, Herpes spp. concentrations were lower in РРС patients than in controls. The study identified differences in bacterial, fungal, and viral gut microbiota components between РРС patients and controls, highlighting the need for further research to define «key microbiota» and its role in MS pathogenesis. controls. It included 14 РРС patients and 14 healthy volunteers. Stool samples were analyzed using Osipov mass spectrometry to measure microbial markers, including fungi and viruses. Statistical analysis, performed using Statsoft Statistica 12, involved normality tests (Kolmogorov-Smirnov, Shapiro-Wilk), Mann-Whitney U tests (p≤0.05). Results showed РРС patients had a significant predominance of Clostridium difficile and Propionibacterium spp., while Kingella spp. and Pseudomonas aeruginosa were absent, distinguishing them from controls. РРС patients also exhibited higher fungal flora levels. Regarding the viral component, Herpes spp. concentrations were lower in РРС patients than in controls. The study identified differences in bacterial, fungal, and viral gut microbiota components between РРС patients and controls, highlighting the need for further research to define «key microbiota» and its role in MS pathogenesis.

  • The problem of differential diagnosis in macro-CPK

    by Federal State Autonomous Educational Institution of Higher Education “Peoples Friendship University of Russia named after Patrice Lumumba”, N.V. Mazurchik, E.V. Garagulya, A. Nduvimana, A.YU. Yakovenko, A.A. Strutsenko, T. A. M. Mkrtchyan

    Macro-CPK is a rare, benign condition that is little known to practicing physicians. Timely diagnosis of macroenzyme presence plays a key role in determining the diagnosis and choosing the correct treatment strategy, as well as prevents a number of unnecessary diagnostic measures, making it an important aspect in clinical practice.

  • A clinical case report of migraine aura without headache

    by N. I. Garabova, M. G. Burzhunova, A. A. Zakaryalova, Makhachkala NikAmed Medical Laboratory Center, E. E. Dunaevskaya, E. A. Kirillova, E. E. Semina, A. A. Strutsenko

    This article examines a clinical case of migraine aura without headache in a 31‑year-old woman who reported experiencing a visual aura resembling «brain fog». A differential diagnosis was conducted to rule out secondary disorders that may have been the cause of her symptoms. Due to the frequency of visual disturbances (up to 12 per month) and the negative impact on the patient's quality of life, she was prescribed sumatriptan 100 mg for acute visual aura attacks. Additionally, cinnarizine 25 mg for a month was recommended for prevention. Following the initiation of treatment, there was a positive response with a reduction in symptoms.

  • Inhumane medicine: imperial japan’s development and the use of biological weapons during World War II

    by Igor’ V. Damulin, Alla A. Strutzenko

    There is currently an acute lack of information on the activities of Japanese doctors during World War II. Being a country with limited natural, financial, and human resources, Imperial Japan considered biological and chemical weapons one of the most promising and effective means of warfare in its quest to dominate Southeast Asia. In the mid 1920s, the Japanese leadership approved biological and chemical warfare research. The implementation of the biological weapons project, including human testing, was entrusted to Shiro Ishii and a group of Japanese scientists under his leadership, as well as to military and civilian experts. These studies examined the effectiveness of plague, gas gangrene, cholera, anthrax, and other pathogens. Experiments, including detailed descriptions of the subjects suffering and the results of autopsies/vivisections, were carefully documented. Field tests involved the distribution of contaminated food and crops to the Chinese population, as well as the contamination of water supplies. Similarly, in keeping with military interests, the effectiveness of munitions and the effects of decompression, hypothermia, and electric current were investigated on prisoners. After the end of World War II and the surrender of Imperial Japan, large-scale buried victims of experiments were found on the territory of the Peoples Republic of China, including the borders of the USSR. The paper focuses on the ethical component of the studies conducted, based on the dominant view in the Japanese society that all actions for the glory of the country and the emperor are justified and the absence of any ethical considerations due to the prejudice of the Japanese against foreigners in general and the Chinese in particular.


  • Post COVID-19 disorders: is the epidemic of parkinsonism threatening the world?

    by I.V. Damulin, A.A. Strutzenko

    В течение пандемии, вызванной SARS-CoV-2, все более очевидной становится способность этого вируса поражать структуры периферической и центральной (ЦНС) нервной системы. Поражение нервной системы отмечается почти у 85% пациентов, перенесших COVID-19, как переболевших этим заболеванием в тяжелой форме, так и с легким или бессимптомным течением. На фоне COVID-19 отмечается ухудшение симптоматики у пациентов с болезнью Паркинсона (БП), что потенциально повышает риск летального исхода вследствие пневмонии и дыхательных расстройств на выраженных стадиях БП. Существует опасение, что пандемия COVID-19 может привести к резкому увеличению заболеваемости паркинсонизмом, при этом предполагается способность вируса SARS-CoV-2 вызывать БП. Рассматриваются следующие пути проникновения вирусов, включая вирус SARS-CoV-2, в структуры ЦНС — виремия и поражение эндотелиальных клеток, а также ретроградный аксональный транспорт. Непосредственное проникновение вируса COVID-19 в структуры головного мозга может быть обусловлено нарушением гематоэнцефалического барьера вследствие «цитокинового шторма» и активации лимфоцитов, что связано с процессами нейровоспаления. По некоторым своим проявлениям экстрапирамидный синдром, отмечающийся у пациентов с COVID-19, напоминает летаргический энцефалит фон Экономо. Однако вопрос о способности COVID-19 вызывать развитие БП является крайне сложным и неоднозначным. Латентный период между перенесенным вирусным энцефалитом и возникновением паркинсонизма может достигать 5 лет. Возможно, что в основе развития неврологических расстройств, включая паркинсонизм, у этой категории больных лежит энергетический дефицит, приводящий к нарушению функционирования нейронных сетей (коннектома) головного мозга человека. На основе имеющихся в настоящее время весьма ограниченных данных, касающихся проникновения вируса COVID-19 в структуры ЦНС, сколь-либо убедительных подтверждений возможности этого вируса вызывать паркинсонизм нет. Окончательную ясность в этот вопрос внесут результаты наблюдений за состоянием больных, перенесших COVID-19.